EBR Systems Advances Cardiac Pacing Device Rollout With 46 Commercial Implants in Q2

MT Newswires Live

Jul 30

EBR Systems (ASX:EBR) reported 46 commercial implants of its WiSE cardiac pacing device for heart failure in the second quarter, bringing total implants across the pilot phase and limited market release to 117, according to a Thursday filing with the Australian bourse.

The company said it signed an additional 17 purchasing contracts during the quarter, taking overall purchasing contracts signed to 52.

It added that 90 physicians at 30 sites are now trained to implant the WiSE system, with 26 of them trained during the second quarter.

Additionally, EBR Systems expects second-quarter revenue in the range of $2.5 million to $2.6 million. It sees "encouraging numbers" of patients being identified and scheduled for WiSE implants in the second half of the year.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/news/2655841058"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2655841058\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2655841058?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-30 11:38","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2655841058","market":"us","top_or_hot":-1,"title":"EBR Systems Advances Cardiac Pacing Device Rollout With 46 Commercial Implants in Q2","media":"MT Newswires Live","content":"<html><body><p> EBR Systems (ASX:EBR) reported 46 commercial implants of its WiSE cardiac pacing device for heart failure in the second quarter, bringing total implants across the pilot phase and limited market release to 117, according to a Thursday filing with the Australian bourse.</p><p>The company said it signed an additional 17 purchasing contracts during the quarter, taking overall purchasing contracts signed to 52.</p><p>It added that 90 physicians at 30 sites are now trained to implant the WiSE system, with 26 of them trained during the second quarter.</p><p>Additionally, EBR Systems expects second-quarter revenue in the range of $2.5 million to $2.6 million. It sees \"encouraging numbers\" of patients being identified and scheduled for WiSE implants in the second half of the year.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>EBR Systems Advances Cardiac Pacing Device Rollout With 46 Commercial Implants in Q2</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEBR Systems Advances Cardiac Pacing Device Rollout With 46 Commercial Implants in Q2\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2026-07-30 11:38</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> EBR Systems (ASX:EBR) reported 46 commercial implants of its WiSE cardiac pacing device for heart failure in the second quarter, bringing total implants across the pilot phase and limited market release to 117, according to a Thursday filing with the Australian bourse.</p><p>The company said it signed an additional 17 purchasing contracts during the quarter, taking overall purchasing contracts signed to 52.</p><p>It added that 90 physicians at 30 sites are now trained to implant the WiSE system, with 26 of them trained during the second quarter.</p><p>Additionally, EBR Systems expects second-quarter revenue in the range of $2.5 million to $2.6 million. It sees \"encouraging numbers\" of patients being identified and scheduled for WiSE implants in the second half of the year.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK7007","symbol_name":"医疗保健设备","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2655841058","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2655841058","pubTimestamp":1785382703,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"EBR Systems (ASX:EBR) reported 46 commercial implants of its WiSE cardiac pacing device for heart failure in the second quarter, bringing total implants across the pilot phase and limited market relea","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK7007":"医疗保健设备","EBR.AU":"EBR SYSTEMS INC-CDI"},"translate_title":"EBR Systems 在第二季度推出 46 台商业植入物，推进心脏起搏设备","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"EBR.AU":1},"content_text":"EBR Systems (ASX:EBR) reported 46 commercial implants of its WiSE cardiac pacing device for heart failure in the second quarter, bringing total implants across the pilot phase and limited market release to 117, according to a Thursday filing with the Australian bourse.The company said it signed an additional 17 purchasing contracts during the quarter, taking overall purchasing contracts signed to 52.It added that 90 physicians at 30 sites are now trained to implant the WiSE system, with 26 of them trained during the second quarter.Additionally, EBR Systems expects second-quarter revenue in the range of $2.5 million to $2.6 million. It sees \"encouraging numbers\" of patients being identified and scheduled for WiSE implants in the second half of the year.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}